StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3043% above fair value
$45.46−3.78 (-7.68%)

Close on Nov 20, 2026Market cap $1.36BP/E –Yield –

GeneDx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

GeneDx's shares outstanding was 30M at Jun 30, 2026. For fiscal 2025 it was 29M, up 6.5% from the year before. The highest annual figure on record is 29M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202529M+6.5%
FY2024Dec 31, 202427M+10.6%
FY2023Dec 31, 202324M+137.5%
FY2022Dec 31, 202210M+212.6%
FY2021Dec 31, 20213M+2112851.0%
FY2020Dec 31, 20200M+3775.0%
FY2019Dec 31, 20190M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202630M-0.1%
Q1 FY2026Mar 31, 202629M+4.2%
Q4 FY2025Dec 31, 202529M+4.6%
Q3 FY2025Sep 30, 202529M+6.3%
Q2 FY2025Jun 30, 202530M+11.8%
Q1 FY2025Mar 31, 202528M+8.0%
Q4 FY2024Dec 31, 202428M+7.2%
Q3 FY2024Sep 30, 202427M+5.1%
Q2 FY2024Jun 30, 202427M+4.7%
Q1 FY2024Mar 31, 202426M+29.9%
Q4 FY2023Dec 31, 202326M+121.0%
Q3 FY2023Sep 30, 202326M+123.5%
Q2 FY2023Jun 30, 202325M+148.3%
Q1 FY2023Mar 31, 202320M+170.9%
Q4 FY2022Dec 31, 202212M+83.9%
Q3 FY2022Sep 30, 202212M+34491.4%
Q2 FY2022Jun 30, 202210M+61334.0%
Q1 FY2022Mar 31, 20227M–
Q3 FY2021Sep 30, 20216M–
Q2 FY2021Jun 30, 20210M–
Q1 FY2021Mar 31, 20210M–
Q3 FY2020Sep 30, 20200M–

More GeneDx figures

See a number that looks wrong?